Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
MEIJI SEIKA PHARMA CO LTD	4-16 KYOBASHI 2-CHOME CHUO-KU TOKYO 104-8002

International Classification(s)

• C07D:HETEROCYCLIC COMPOUNDS

• 2009 Application Filing Year
• C07D Class
• 4223 Applications Filed
• 2150 Patents Issued To-Date
• 50.92 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Kagabu, Shinzo	Gifu, JP	51	914
# of filed Patents : 51 Total Citations : 914
Kumazawa, Satoru	Iwaki, JP	40	186
# of filed Patents : 40 Total Citations : 186
Mori, Masaru	Iwaki, JP	21	391
# of filed Patents : 21 Total Citations : 391

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• C07D Class

• 0 % this patent is cited more than
• 13 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
November 13, 2012	US,8309733,B2   US8309733B2	GRANTED PATENT AS SECOND PUBLICATION
July 14, 2011	US,20110172433,A1   US20110172433A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent Application No: 2017/0058,349

METHODS FOR MANAGING CARE OF PATIENTS PREDISPOSED TO PROGRESSIVE MITRAL VALVE DISEASES

---

Abstract

---

The present invention relates to methods for treating or preventing a mitral valve disease in a subject in need thereof, comprising administering to the subject an effective amount of a therapeutic agent. The therapeutic agent is capable of suppressing serotonin receptor signaling. The methods may be combined with a mitral valve surgery, serotonin transporter polymorphism genotyping, MV disease diagnosis, and/or an adjunct assay. Also provided are related medicaments, pharmaceutical compositions, and methods for preparing the medicaments.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.